Purchase Order 75F40124P00101
Award Date 3/22/24
Potential Completion Date 3/23/29
Potential Value $818K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Laurel, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic analysis technologies. The contract, with a ceiling value of $417,372.48, is for preventative maintenance services on Illumina's NextSeq 2000 and NextSeq 500 sequencing platforms. The award does not utilize a set-aside designation. Illumina is a leading provider of genetic sequencing instruments, reagents, and...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for $170,153.16 to provide annual on-site preventative maintenance service and unlimited repairs as needed on two Illumina MiSeq whole genome sequencers for a base year plus four option years. The contract has no set-aside designation. Based on Illumina's history as a prime contractor and subcontractor for sequencing systems and services across various federal agencies, this award aligns...
- This is a $142,142.04 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit biotechnology manufacturer, for annual maintenance of the agency's Illumina NextSeq2000 genetic sequencing instruments. The contract does not have a set-aside designation. Illumina has two significant Indefinite Delivery Vehicles (IDVs) with the U.S. Department of Agriculture and Department of Veterans Affairs for providing a range of genomic sequencing...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the service and maintenance of one Illumina MiSeq sequencing system, with a ceiling value of $34,972.40 and a performance period ending on September 24, 2024. Illumina, a for-profit organization and manufacturer of goods, has been awarded numerous prime federal contracts and...
- This firm fixed-price delivery order, valued at $201,939.00, was awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for preventative maintenance services on MiSeq benchtop sequencing instruments. The award does not have a set-aside designation. Illumina is a manufacturer of genetic sequencing systems and has a history of supporting genomic research and diagnostics across multiple federal agencies. This award indicates Illumina is providing maintenance services to help ensure the...
- This is a firm-fixed price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract is for a 12-month preventative maintenance service agreement with four 12-month option periods, to support five MiSeq sequencing instruments for the FDA's Center for Food Safety and Applied Nutrition (CFSAN). The contract has a ceiling value of $425,145.40 and does not utilize a...
- This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract has a ceiling value of $924,805.20 and a period of performance ending on March 23, 2019. The award is for the provision of high-throughput sequencing equipment and services, with no set-aside designation. Illumina has a history of supporting genomic sequencing and analysis requirements across various...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $66,483.01, is for a Preventive Maintenance and Repair Agreement for an Illumina MiSeq system. The contract has an ultimate completion date of May 16, 2025 and does not utilize any set-aside designations. Illumina has been awarded numerous prime federal contracts and grants...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is for $12,450.00 to provide preventative maintenance services for Illumina's MISEQ sequencing system. The contract has an ultimate completion date of June 30, 2018 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing instruments and related technologies. The contract, valued at $88,966.00, is for preventative maintenance services on a NextSeq sequencing instrument (serial number NS500253) used by the FDA. The contract does not have a set-aside designation. Illumina is the prime contractor and there is no information provided about any...